- Report
- March 2022
- 198 Pages
Global
From €3906EUR$4,450USD£3,378GBP
- Report
- February 2026
- 150 Pages
India
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2026
- 150 Pages
Canada
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2026
- 150 Pages
China
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2026
- 175 Pages
India
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2026
- 182 Pages
China
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2026
- 174 Pages
Germany
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2026
- 178 Pages
Japan
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2026
- 173 Pages
Canada
From €4257EUR$4,850USD£3,682GBP
- Report
- December 2025
- 150 Pages
Germany
From €4257EUR$4,850USD£3,682GBP
- Report
- December 2025
- 150 Pages
Germany
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
India
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
India
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
Japan
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
Japan
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
China
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
China
From €4257EUR$4,850USD£3,682GBP
- Report
- April 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- April 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- April 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more